Deep vein thrombosis epidemiology and demographics

Revision as of 04:14, 14 May 2012 by Kashish Goel (talk | contribs)
Jump to navigation Jump to search

Editors-in-Chief: C. Michael Gibson, M.S., M.D. Associate Editor-In-Chief: Ujjwal Rastogi, MBBS [1]

Deep Vein Thrombosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Deep vein thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Approach

Assessment of Clinical Probability and Risk Scores

Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Venography

CT

MRI

Other Imaging Findings

Treatment

Treatment Approach

Medical Therapy

IVC Filter

Invasive Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenario

Upper extremity DVT

Recurrence

Pregnancy

Trials

Landmark Trials

Case Studies

Case #1

Deep vein thrombosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Deep vein thrombosis epidemiology and demographics

CDC on Deep vein thrombosis epidemiology and demographics

Deep vein thrombosis epidemiology and demographics in the news

Blogs on Deep vein thrombosis epidemiology and demographics

Directions to Hospitals Treating Deep vein thrombosis

Risk calculators and risk factors for Deep vein thrombosis epidemiology and demographics

Overview

Deep Vein Thrombosis is highly prevalent in the general population of USA and accounts for approximately 150,000 deaths in a year. Its prevalence is estimated to be 100 cases/100,000 persons/year in US.

Over 200,000 new cases of VTE occur annually. About two-thirds of episodes manifest as DVT and one-third as PE with or without DVT. Of these, 30 percent die within 30 days, one-fifth suffer sudden death due to PE, and about 30 percent develop recurrent VTE within 10 years. Independent predictors for recurrence include increasing age, obesity, malignant neoplasm and extremity paresis.

Prevalence by Age

DVT is much more common in the elderly population as compared to pediatrics. About 1 in 100,000 people under the age of 18 experiences deep vein thrombosis, possibly due to

  • Children heartrate being higher than adult
  • Relatively active lifestyle when compared with adults
  • Fewer comorbidities (e.g. malignancy).

Age greater than 45 is significantly associated with increased incidence of DVT.[1]

Prevalence by Gender

Males gender is associated with a higher risk than female gender, and the risk increases with age in both genders.

In studies conducted in Worcester, Massachusetts, and Olmsted County, Minnesota, the incidence of Venous thromboembolism (VTE) was about 1 in 1,000. In both studies, VTE was more common in men; for each 10-year increase in age, the incidence doubled. By extrapolation, it's estimated that more than 250,000 patients are hospitalized annually with VTE.[2]

Prevalence by Race

Caucasians and African Americans have a significantly higher incidence than Hispanics and Asians or Pacific Islanders.[3] Observed ethnic differences in thrombosis incidence might be related to a lower prevalence of disorders like factor V Leiden or the prothrombin 20210A mutation in non-Caucasians.[4][5]

References

  1. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P; et al. (2004). "Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology". Am J Med. 117 (1): 19–25. doi:10.1016/j.amjmed.2004.01.018. PMID 15210384.
  2. Goldhaber SZ (1998). "Pulmonary embolism". N Engl J Med. 339 (2): 93–104. doi:10.1056/NEJM199807093390207. PMID 9654541.
  3. White RH (2003). "The epidemiology of venous thromboembolism". Circulation. 107 (23 Suppl 1): I4–8. doi:10.1161/01.CIR.0000078468.11849.66. PMID 12814979.
  4. Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997). "Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening". JAMA. 277 (16): 1305–7. PMID 9109469.
  5. Gregg JP, Yamane AJ, Grody WW (1997). "Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations". Am J Med Genet. 73 (3): 334–6. PMID 9415695.

Template:WH Template:WS